‘Z-trip’? A Comprehensive Overview and a Case-series of Zolpidem Misuse

Author:

Orsolini Laura12ORCID,Chiappini Stefania2ORCID,Grandinetti Paolo3ORCID,Bruschi Angelo456ORCID,Testa Roberta7,Provenzano Alessandra8,Berardis Domenico De910ORCID,Volpe Umberto1ORCID

Affiliation:

1. Unit of Clinical Psychiatry, Department of Neurosciences/DIMSC, School of Medicine and Surgery, Polytechnic University of Marche, Ancona, Italy

2. Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, UK

3. NHS, Department of Territorial Assistance, Service for Addictions (SerD), Teramo, Rome

4. NHS, Department of Mental Health, Psychiatric Service of Diagnosis and Treatment, Belcolle Hospital, Viterbo, Rome

5. Catholic University of the Sacred Heart, Rome

6. Istituto di Psicopatologia, Rome

7. NHS, Department of Mental Health, AUSL Reggio Emilia, Reggio Emilia, Rome

8. NHS, Department of Mental Health, ASL Viterbo, Viterbo, Rome

9. NHS, Department of Mental Health, Psychiatric Service of Diagnosis and Treatment, G. Mazzini Hospital, Teramo, Rome

10. Department of Neuroscience, Imaging and Clinical Science, G. D’Annunzio University, Chieti, Italy

Publisher

Korean College of Neuropsychopharmacology

Subject

Pharmacology (medical),Behavioral Neuroscience,Psychiatry and Mental health

Reference103 articles.

1. National Institute for Health and Care Excellence (NICE). Guidance on the use of zaleplon, zolpidem and zopiclone for the shortterm management of insomnia. London:National Institute for Health and Care Excellence (NICE);2004.

2. Medicines associated with dependence or withdrawal: a mixed-methods public health review and national database study in England

3. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update

4. Zolpidem

5. Siriwardena AN, Qureshi Z, Gibson S, Collier S, Latham M. GPs’ attitudes to benzodiazepine and 'Z-drug’ prescribing: a barrier to implementation of evidence and guidance on hypnotics. Br J Gen Pract 2006;56:964-967.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3